Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'neuropeptide y 13 36 porcine'

Search results for: 'neuropeptide y 13 36 porcine'

Items 11-20 of 61

Page
per page
  1. Pirfenidone
    B2288 Pirfenidone
    Summary: TGF-β production inhibitor
  2. Compound 56
    A8197 Compound 56
     1 Citation
    Target: EGFR
    Summary: REGFR inhibitor
      insoluble in H2O; ≥16.95 mg/mL
  3. MK-2206 dihydrochloride
    A3010 MK-2206 dihydrochloride
     21 Citation
    Target: Akt
    Summary: Akt1/2/3 inhibitor
      insoluble in EtOH; ≥12.01 mg/mL
  4. MLN8054
    A4114 MLN8054
    Target: Aurora Kinases
    Summary: Aurora A inhibitor
      insoluble in EtOH; insoluble in H2O; ≥39.05 mg/mL
  5. Tolcapone
    A4383 Tolcapone
    Target: Catechol O-Methyltransferase (COMT)
    Summary: COMT inhibitor
      insoluble in H2O; ≥12 mg/mL
  6. AZD8186
    B5950 AZD8186
    Target: PI3K
    Summary: Potent and selective inhibitor of PI3Kβ and PI3Kδ
      insoluble in H2O; insoluble in EtOH; ≥45.7 mg/mL
  7. DIDS
    B7675 DIDS
    Target: voltage-gated chloride channels
    Summary: anion transport inhibitor
      insoluble in H2O; insoluble in EtOH; insoluble in DMSO
  8. Lithium carbonate
    B7705 Lithium carbonate
    Target: Na /K ATPases
    Summary: Na+/K+ ATPase pump inhibitor
      insoluble in EtOH; ≥2.74 mg/mL
  9. PhiKan 083
    A4481 PhiKan 083
    Target: p53
    Summary: p53 stabilizer
      <13.74 mg/mL
  10. Perindopril Erbumine
    A8019 Perindopril Erbumine
    Target: Angiotensin-Converting Enzymes (ACEs)
    Summary: ACE inhibitor
      ≥111.4 mg/mL

Items 11-20 of 61

Page
per page
Shop By
Now Shopping by
  1. Reported Experiments Cell Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 60item
  2. Natural Products 1 item
  3. Lab Reagents 1 item
Specificity
  1. Selective 34item
Reversibility
  1. Reversible 1 item
Target
  1. Cyclin-Dependent Kinases 1 item
  2. Histone Deacetylases (HDACs) 2item
  3. Akt 3item
  4. PI3K 6item
  5. Raf 2item
  6. Aurora Kinases 2item
  7. mTOR 4item
  8. MMP 2item
  9. Androgen Receptors 1 item
  10. FLT3 1 item
  11. Farnesoid X receptors (FXRs) 1 item
  12. LPA Receptors 1 item
  13. P-glycoprotein (P-gp) 1 item
  14. PLK 1 item
  15. Eph Receptors 1 item
  16. VEGFR 5item
  17. PDGFR 4item
  18. c-Kit 2item
  19. RET 1 item
  20. Phosphodiesterases (PDEs) 1 item
  21. Bcr-Abl 1 item
  22. FGFR 2item
  23. Sir2-like Family Deacetylases (Sirtuins) 1 item
  24. Voltage-gated Sodium (NaV) Channels 1 item
  25. Src 1 item
  26. EGFR 1 item
  27. ROCK 2item
  28. DNA-PK 3item
  29. HSP90 1 item
  30. Topoisomerases 1 item
  31. Cytochrome P450 (CYP450) 2item
  32. Toll-like receptors (TLRs) 1 item
  33. PKC 2item
  34. LRRK2 1 item
  35. ALK 1 item
  36. PKG 2item
  37. PKA 2item
  38. Myosin light chain kinases (MLCKs) 1 item
  39. Angiotensin-Converting Enzymes (ACEs) 1 item
  40. Autophagy 1 item
  41. ATM/ATR 1 item
  42. COX 1 item
  43. CK1 1 item
  44. Glutamate (Metabotropic) Group I Receptors 1 item
  45. NPY Receptors 2item
  46. Histamine H1 Receptors 1 item
  47. Na /K ATPases 1 item
  48. P110 1 item
  49. Hck 1 item
  50. Catechol O-Methyltransferase (COMT) 1 item
  51. angiogenesis 1 item
  52. voltage-gated chloride channels 1 item
  53. sodium channels 1 item
  54. p53 1 item
  55. LOX 1 item
  56. Adenylyl cyclase 1 item
  57. Quinone reductase 1 item
  58. sodium channel 1 item
  59. Vitamin D receptors (VDRs) 1 item
  60. adrenergic receptor 1 item
  61. Histone Acetyltransferases (HATs) 1 item
  62. NPFF receptor 1 item
  63. Prk 1 item
  64. potassium channel 1 item
  65. calcium channel 1 item
  66. Pregnane X receptor(PXR) 1 item
  67. NOD1 1 item
  68. DCLK2 1 item
  69. DNA gyrase 1 item
  70. prolactin secretion 1 item
  71. gonadotropin release 1 item
  72. TRPC channel 1 item
  73. GABAA receptor 1 item
  74. gp120/CD4 1 item
  75. ATM 1 item
Related Disease
  1. Adrenocortical Carcinoma 1 item
  2. Bladder Cancer 1 item
  3. Brain Injuries Studies 1 item
  4. Breast Cancer 4item
  5. Cancer 24item
  6. Chronic Lymphocytic Leukemia 2item
  7. Chronic Myeloproliferative Disorders 1 item
  8. Clear Cell Renal Cell Carcinoma 1 item
  9. Cocaine-Related Disorders 1 item
  10. Colon Cancer 1 item
  11. Colorectal Cancer 3item
  12. Diabetes 1 item
  13. Glioblastoma 2item
  14. Glioma 2item
  15. HIV 1 item
  16. Lung Cancer 1 item
  17. Lymphoma 1 item
  18. Multiple Myeloma 3item
  19. Myelofibrosis 1 item
  20. Neuroblastoma 3item
  21. Neurocognitive Disorders 1 item
  22. Non-small Cell Lung Carcinoma 1 item
  23. Obsessive-Compulsive Disorder 1 item
  24. Osteoporosis 1 item
  25. Ovarian Cancer 2item
  26. Pancreatic Cancer 1 item
  27. Prostate Cancer 2item
  28. Pulmonary Fibrosis 1 item
  29. Renal Cancer 1 item
  30. Schizophrenia 1 item
  31. Soft Tissue Sarcoma 1 item
  32. Thyroid Cancer 1 item